Surrozen, Inc.

NASDAQ:SRZN

Biotechnology

Healthcare
$30.67 -4.74%

-$1.14 today

Market cap
$229.33M
Beta
0.51
P/E (TTM)
-0.7
EPS (TTM)
-$31.29
52W Low $8.00High $35.00

Volume 0.09M

Average 0.11M

Returns on capital

Surrozen, Inc. management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management
Older years hidden. Sign in to unlock

ROE

128.9%

avg 9.4%

ROIC

-46.7%

avg -62.0%

ROA

-245.1%

avg -94.0%

Analysis

ROE is currently the strongest return metric at 128.9% versus its period average of 9.4%. 1 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

Craig C. Parker

Chief Executive Officer, President & DirectorUSD 976.5K6418.18K0.24%

Charles Williams

Chief Operating Officer & Corporate SecretaryUSD 689.79K46——

Yang Li

Executive Vice President of ResearchUSD 642.1K5718.88K0.25%

Esther Jhun

Controller————

Andrew Maleki

Chief Financial Officer—36——

Michael Lauw

Senior Vice President of Development Operations————

Calvin Kuo

Co-Founder & Member of Scientific Advisory Board————

K. Christopher Garcia

Co-Founder & Member of Scientific Advisory Board————

Roeland Nusse

Co-Founder & Member of Scientific Advisory Board—76——

Daniel L. Chao

Vice President and Head of Clinical Development————

Compensation is shown in the reported currency; data updated Nov 7, 2026.

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Jun 15, 2026.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

Buys

52

$8.87M

Sells

7

$7.23M

Net Transaction Value

+$1.64M

Net buying

Most Active

TCG Crossover GP II, LLC

22 transactions

Transactions sorted by date, descending.

Open-market insider purchases and sales reported during the last 12 months
Type
Jul 22, 26

TCG Crossover GP II, LLC

Indirect

Sell$3.5M
Jul 22, 26

TCG Crossover GP II, LLC

Indirect

Sell$3.5M
May 4, 26

Li Yang

Direct

Sell$52.8K
May 4, 26

Parker Craig C

Direct

Sell$150.8K
May 4, 26

Williams Charles O

Direct

Sell$67.9K
Mar 24, 26

TCG Crossover GP II, LLC

Indirect

Buy$1.3M
Mar 24, 26

TCG Crossover GP II, LLC

Indirect

Buy$1.3M
Mar 23, 26

TCG Crossover GP II, LLC

Indirect

Buy$189.5K
Mar 23, 26

TCG Crossover GP II, LLC

Indirect

Buy$189.5K
Mar 16, 26

TCG Crossover GP II, LLC

Indirect

Buy$14.9K

1–10 of 59

Summary

Insiders reported 52 buys worth $8.87M and 7 sells worth $7.23M over the last 12 months. That adds up to net buying of $1.64M. TCG Crossover GP II, LLC was the most active insider with 22 transactions.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A1 analysts
RevenueN/AN/A-34.7%
-9.6% (5yr)2 analysts
Net IncomeN/AN/AN/A
N/A2 analysts
EBITN/AN/AN/A
N/A2 analysts

Analysis

Recent growth has been strongest in Revenue at -34.7% over three years. Forward estimates point to Revenue at -9.6% (5yr), giving you a quick check on whether expectations are accelerating or cooling.

Competitors

Who does Surrozen, Inc. compete with?

Open similar companies to compare how their management teams allocate capital.

Questions

Management questions

Common questions about SRZN's management, answered from reported figures.

Who manages SRZN?

Surrozen, Inc. (SRZN) lists 10 active executives. The top listed executive is Esther Jhun, Controller.

Are SRZN insiders buying or selling?

Recent insider activity shows net buying of $92.57M.